Triasima Portfolio Management inc. Invests $4.87 Million in Axon Enterprise, Inc. (NASDAQ:AXON)

Triasima Portfolio Management inc. bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 8,201 shares of the biotechnology company’s stock, valued at approximately $4,874,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Asset Dedication LLC raised its position in shares of Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after acquiring an additional 18 shares in the last quarter. Bleakley Financial Group LLC increased its position in Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after buying an additional 20 shares during the period. Insigneo Advisory Services LLC lifted its stake in Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after buying an additional 22 shares during the last quarter. Menard Financial Group LLC lifted its stake in Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares during the last quarter. Finally, PFG Investments LLC lifted its stake in Axon Enterprise by 0.6% in the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after buying an additional 25 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Down 0.5 %

Shares of AXON stock opened at $677.40 on Friday. The business’s fifty day moving average price is $622.79 and its 200 day moving average price is $491.30. Axon Enterprise, Inc. has a 1-year low of $255.68 and a 1-year high of $698.67. The firm has a market capitalization of $51.65 billion, a PE ratio of 175.04, a P/E/G ratio of 6.54 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on AXON shares. Northland Securities boosted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird boosted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities boosted their price objective on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research note on Tuesday. Finally, Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $542.15.

Insider Buying and Selling

In related news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock valued at $30,721,337 over the last quarter. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.